| |
|
|
Bukwang Pharmaceutical Co.,Ltd (003000) |
|
|
STOCK |
|
|
|
  |
(Unit : %, Times) |
| Fiscal Year End |
2007. 3.31 | 2008. 3.31 | 2009. 3.31 | 2010. 3.31 | 2010. 9.30 |
| Net Income to Total Assets |
13.86 | 18.26 | 14.13 | 11.69 | 8.39 |
| Ordinary Income to Total Assets |
19.60 | 25.30 | 18.29 | 15.46 | 12.68 |
| Operating Profit to Working Capital |
20.31 | 26.53 | 22.81 | 21.50 | 21.50 |
| Net Income to Equity |
16.74 | 22.63 | 18.35 | 15.41 | 11.03 |
| Net Income to Sales |
14.21 | 21.12 | 19.11 | 16.32 | 12.38 |
| Ordinary Income to Sales |
20.10 | 29.26 | 24.74 | 21.58 | 18.72 |
| Operating Income to Sales |
19.27 | 27.09 | 24.84 | 22.88 | 19.53 |
| Total Income to Sales |
56.21 | 62.52 | 59.69 | 57.46 | 56.75 |
| Times Interest earned |
- | 6,503,321.57 | 25.92 | 16.90 | 14.67 |
| Financial Expenses/Sales |
- | - | 0.99 | 1.36 | 1.37 |
| Equity to Total Assets |
83.08 | 79.03 | 75.08 | 76.56 | 75.59 |
| Liability to Equity |
20.37 | 26.54 | 33.19 | 30.62 | 32.29 |
| Borrowings & Bonds to Assets |
- | - | 13.26 | 11.97 | 11.97 |
| Current Liabilities to Equity |
17.54 | 24.64 | 13.31 | 12.21 | 28.79 |
| Fixed Assets to Equity & L/T Liabilities |
36.10 | 37.18 | 42.72 | 40.00 | 48.64 |
| Fixed Ratio |
37.12 | 37.89 | 51.22 | 47.37 | 50.34 |
| Current Ratio |
474.62 | 359.84 | 615.73 | 681.70 | 284.69 |
| Quick Ratio |
386.97 | 278.35 | 453.36 | 522.40 | 215.23 |
| Debt Coverage Ratio |
- | 524,997,200.00 | 2,264.44 | 1,433.53 | 92.76 |
| Total C/F to Liabilities |
102.39 | 87.45 | 70.21 | 65.03 | - |
| Business Capital Turn over |
1.05 | 0.98 | 0.92 | 0.94 | 0.85 |
| Total Assets Turn over |
0.98 | 0.86 | 0.74 | 0.72 | 0.68 |
| Trade Receivables Turn over |
3.10 | 3.04 | 2.53 | 2.11 | 1.85 |
| Inventories Turn over |
7.07 | 5.93 | 4.61 | 4.61 | 4.51 |
| Trade Payables Turn over |
20.63 | 25.62 | 26.45 | 27.33 | 23.24 |
| Sales Growth |
8.83 | 13.15 | 3.75 | 5.80 | 0.03 |
| Total Asset Growth |
12.73 | 40.73 | 7.54 | 10.75 | 0.06 |
| Equity Growth |
13.53 | 33.87 | 2.17 | 12.92 | - 1.20 |
|
  |
(Unit : %) |
| Fiscal Year End |
2006. 3.31 | 2007. 3.31 | 2008. 3.31 | 2009. 3.31 | 2010. 3.31 |
| Cost of Sales |
47.58 | 43.79 | 37.48 | 40.31 | 42.54 |
| Selling & General Adm.Exp. |
36.08 | 36.94 | 35.42 | 34.86 | 34.59 |
| R & D Costs |
- | - | - | - | - |
| Depreciation |
2.73 | 2.38 | 2.25 | 2.14 | 1.56 |
| Financial Expenses |
0.06 | - | - | 0.99 | 1.36 |
| Operating Income |
16.34 | 19.27 | 27.09 | 24.84 | 22.88 |
| Ordinary Income |
- | - | - | - | - |
| Income before Income Taxes |
17.02 | 20.10 | 29.26 | 24.74 | 21.58 |
| Net Profit |
12.90 | 14.21 | 21.12 | 19.11 | 16.32 |
|
  |
(Unit : 100Mn. Won, %) |
| Fiscal Year End |
2006. 3.31 | 2007. 3.31 | 2008. 3.31 | 2009. 3.31 | 2010. 3.31 |
| Total Debt |
- | - | - | 300.0 | 300.0 |
| Short-Term Debt |
- | - | - | - | - |
| Current Portion of L/T Debt |
- | - | - | - | - |
| Long-Term Debt |
- | - | - | 300.0 | 300.0 |
| Short-Term Debt to Total Debt |
- | - | - | - | - |
|
|
|
|